BFG
RPRX icon

Bleakley Financial Group’s Royalty Pharma RPRX Stock Holding History

Bleakley Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$820K Buy
14,626
+3,659
+33% +$190K 0.01% 700
2026
Q1 		$526K Buy
10,967
+847
+8% +$37.1K 0.01% 624
2025
Q4 		$391K Buy
+10,120
New +$386K 0.01% 621
2025
Q3 		– Sell
-10,763
Closed -$388K – 611
2025
Q2 		$388K Buy
+10,763
New +$357K 0.01% 515

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleakley Financial Group's RPRX Position: Q2 2026 in Review

Bleakley Financial Group increased its Royalty Pharma (RPRX) stake by 33% in Q2 2026, buying an estimated $190K and bringing the position to 14,626 shares worth $820K. The position accounts for 0.01% of the portfolio, ranked #700.

Bleakley Financial Group first reported a position in RPRX in Q2 2025 and has held it in 4 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Bleakley Financial Group held 14,626 shares of Royalty Pharma worth $820K as of Q2 2026.
  • Bleakley Financial Group bought 3,659 Royalty Pharma shares in Q2 2026, an estimated $190K.
  • Royalty Pharma made up 0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #700 holding.
  • Bleakley Financial Group first reported a position in Royalty Pharma in Q2 2025 and has held it in 4 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.